Jeffrey Lazarus

Barcelona Institute for Global Health Hospital Clínic – University of Barcelona, Barcelona, Spain

Prof Jeffrey V. Lazarus (PhD, MIH, MA) is the head of the Health Systems Research Group and co-director of the Viral and Bacterial Infections Programme at the Barcelona Institute for Global Health (ISGlobal) and Associate Professor at the University of Barcelona at ISGlobal and Associate Professor at the University of Barcelona as well as a senior scholar at the CUNY Graduate School of Public Health and Health Policy.

His decade-long career as a health systems, HIV and viral hepatitis expert at WHO’s Regional Office for Europe was followed by three years at the Global Fund to Fight AIDS, Tuberculosis and Malaria. He is the past Vice-Chair of the EASL International Liver Foundation, Board Chair of AFEW International and he was the first director of Health Systems Global. He currently serves as co-chair of the HIV Outcomes Beyond Viral Suppression coalition, a member of the board of directors of the SHARE Global Health Foundation and as a member of the EASL Public Health and Policy Committee and the Global NASH Council.

He is the author of more than 300 publications, including the Global COVID-19 Consensus Statement (Nature 2022) and multiple studies on COVID-19 vaccines hesitancy including in Nature Medicine and Nature Communications and has been advising governments, NGOs and WHO, as well as frequently appearing in the media to address pressing issues about the pandemic.

As Principal Investigator (PI) of the HCV Free Baleares, EU-COMSAVAC, COVID-VAC and the NAFLD public health and global policy studies he has had continued competitive funding for over a decade, since leaving WHO. He is a co-author of The Lancet COVID-19 Commission, the Lancet GastroHep Commission on viral hepatitis and the EASL-Lancet European Liver Commission and led The Lancet HIV series on HIV Beyond Viral Suppression. He is on the editorial board of HIV Medicine, the International Journal of Drug Policy and the Journal of Hepatology.

 He earlier served as Professor at LUHS Medical Academy, Lithuania, and as Affiliated Professor at the WHO Collaborating Centre on HIV and Viral Hepatitis at Rigshospitalet, the University of Copenhagen, and at the University of Porto, Portugal.